After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...

Elevance Health's financial outlook for FY 2025 anticipates GAAP diluted earnings per share (EPS) to be in the range of $30.40 to $31.10 and adjusted diluted EPS to be in the range of $34.15 to $34.85 ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and HIV, at their affiliated ...

The Big 3 PBMs’ affiliated pharmacies generated $7.3 billion in revenue above estimated acquisition costs from 2017-2022. Plan sponsors’ spending on specialty generics rose by 21% yearly for ...

The report, which levels the same allegations at CVS and Cigna, is the latest indictment of America’s broken healthcare ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.